Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galectin Therapeutic
(NQ:
GALT
)
3.500
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.500
Bid (Size)
2.340 (1)
Ask (Size)
4.710 (10)
Prev. Close
3.500
Today's Range
3.500 - 3.500
52wk Range
1.280 - 4.268
Shares Outstanding
59,395,805
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
Performance
YTD
+101.15%
+101.15%
1 Month
+47.68%
+47.68%
3 Month
+95.53%
+95.53%
6 Month
+68.27%
+68.27%
1 Year
+98.86%
+98.86%
More News
Read More
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
April 05, 2024
Via
InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Via
The Motley Fool
Galectin Therapeutics: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Recap: Galectin Therapeutics Q1 Earnings
May 16, 2022
Via
Benzinga
More Personal Portfolio: Biotech, Commodities, And Gold
September 24, 2023
Via
Talk Markets
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
July 21, 2023
Via
Benzinga
7 Short-Interest Stocks to Target for Explosive Gains
May 18, 2023
Via
InvestorPlace
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
Around $30 Million Bet On This Communication Services Stock? 4 Penny Stocks Insiders Are Buying
August 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 06, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 14, 2022
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Via
Benzinga
62 Biggest Movers From Yesterday
June 02, 2022
Via
Benzinga
Galectin Therapeutics: Q4 Earnings Insights
March 31, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 04, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 10, 2021
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 29, 2022
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
August 02, 2021
Via
Benzinga
61 Biggest Movers From Yesterday
August 03, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.